Rachael Sirianni to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Rachael Sirianni has written about Xenograft Model Antitumor Assays.
Connection Strength
0.293
-
Chaudhuri S, Fowler MJ, Baker C, Stopka SA, Regan MS, Sablatura L, Broughton CW, Knight BE, Stabenfeldt SE, Agar NYR, Sirianni RW. ?-Cyclodextrin-poly (?-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors. ACS Appl Mater Interfaces. 2021 May 12; 13(18):20960-20973.
Score: 0.185
-
Chimento A, Casaburi I, Bartucci M, Patrizii M, Dattilo R, Avena P, And? S, Pezzi V, Sirianni R. Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells. Cell Death Dis. 2013 Aug 01; 4:e747.
Score: 0.108